USPTFS: Hepatitis B screening

Article

Published in JAMA Network, a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

Dr. Bobby LazzaraPublished in JAMA Network a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

The US Preventative Services Task Force commissioned a reaffirmation evidence update looking at any new evidence solid enough to institute a change in any prior recommendations.

Findings of the review indicated that serologic testing identifies the infection, and Current Interventions are effective for preventing perinatal transmission.

As a result the US Preventative Services Task Force reaffirmed its position that screening for hepatitis B virus provides substantial benefit in pregnant women and should be accomplished at their first prenatal visit.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.